The KDM1A small molecule inhibitor, NCL-1, reduced cell viability and proliferation and induced apoptosis in neuroblastoma cell lines with different molecular drivers of high-risk disease as well as mouse xenograft models derived from two neuroblastoma cell lines. The gene discussed is KDM1A; the disease is neuroblastoma.